232 related articles for article (PubMed ID: 24389906)
21. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
[TBL] [Abstract][Full Text] [Related]
22. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
[TBL] [Abstract][Full Text] [Related]
23. [A comparative randomized prospective multicenter study of Sandimmune vs Neoral in liver transplantation].
Roy A; Grant DR; Kneteman NM; Tchervenkov JI; Levy GA; Tan A; Hendricks L
Ann Chir; 1998; 52(8):716-21. PubMed ID: 9846420
[TBL] [Abstract][Full Text] [Related]
24. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic drug monitoring of tacrolimus in cardiac transplant recipients: a comparison with cyclosporine neoral.
Wang CH; Ko WJ; Chou NK; Wang SS
Transplant Proc; 2004 Oct; 36(8):2386-7. PubMed ID: 15561257
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the pharmacokinetics of tacrolimus and microemulsified cyclosporin in paediatric renal transplant recipients.
Renton KW; Crocker JF; McLellan H; Acott PD
Eur J Clin Pharmacol; 2004 Aug; 60(6):421-6. PubMed ID: 15232662
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic evaluation of MFF in combinations with tacrolimus and cyclosporine. Findings of C0 and AUC.
Radzevičienė A; Stankevičius E; Saint-Marcoux F; Marquet P; Maslauskienë R; Kaduševičius E
Medicine (Baltimore); 2020 Mar; 99(12):e19441. PubMed ID: 32195940
[TBL] [Abstract][Full Text] [Related]
28. Measurement of cyclosporine A in rat tissues and human kidney transplant biopsies--a method suitable for small (<1 mg) samples.
Noll BD; Coller JK; Somogyi AA; Morris RG; Russ GR; Hesselink DA; van Gelder T; Sallustio BC
Ther Drug Monit; 2011 Dec; 33(6):688-93. PubMed ID: 22105584
[TBL] [Abstract][Full Text] [Related]
29. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
[TBL] [Abstract][Full Text] [Related]
30. Tacrolimus pharmacokinetics in lung transplantation: new strategies for monitoring.
Ragette R; Kamler M; Weinreich G; Teschler H; Jakob H
J Heart Lung Transplant; 2005 Sep; 24(9):1315-9. PubMed ID: 16143250
[TBL] [Abstract][Full Text] [Related]
31. Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation Time.
Aouam K; Chadli Z; Hammouda M; Fredj NB; Aloui S; May ME; Boughattas N; Skhiri H; Chaabane A
Ther Drug Monit; 2015 Aug; 37(4):524-30. PubMed ID: 25627405
[TBL] [Abstract][Full Text] [Related]
32. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases.
Büchler M; Chadban S; Cole E; Midtvedt K; Thervet E; Prestele H; Keown P
Nephrol Dial Transplant; 2006 Jan; 21(1):197-202. PubMed ID: 16204301
[TBL] [Abstract][Full Text] [Related]
33. Establishment of a Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Immunosuppressant Levels in the Peripheral Blood Mononuclear Cells of Chinese Renal Transplant Recipients.
Chen B; Lu JQ; Shao K; Zhai XH; An HM; Shi HQ; Zhou PJ
Ther Drug Monit; 2020 Oct; 42(5):686-694. PubMed ID: 32858576
[TBL] [Abstract][Full Text] [Related]
34. Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients.
Frauca E; Diaz MC; de la Vega A; Hierro L; Camarena C; Muñoz Bartolo G; Díez R; Murcia J; Gámez M; Sanchez Peinado C; López Santamaría M; Andrés I; Jara P
Pediatr Transplant; 2007 Aug; 11(5):530-5. PubMed ID: 17631022
[TBL] [Abstract][Full Text] [Related]
35. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
Kyllönen LE; Salmela KT
Transplantation; 2006 Apr; 81(7):1010-5. PubMed ID: 16612277
[TBL] [Abstract][Full Text] [Related]
36. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
[TBL] [Abstract][Full Text] [Related]
37. Longitudinal Pharmacokinetics of Tacrolimus in Elderly Compared With Younger Recipients in the First 6 Months After Renal Transplantation.
David-Neto E; Romano P; Kamada Triboni AH; Ramos F; Agena F; Almeida Rezende Ebner P; Altona M; Galante NZ; Brambate Carvalhinho Lemos F
Transplantation; 2017 Jun; 101(6):1365-1372. PubMed ID: 27482958
[TBL] [Abstract][Full Text] [Related]
38. A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration.
McAlister VC; Mahalati K; Peltekian KM; Fraser A; MacDonald AS
Ther Drug Monit; 2002 Jun; 24(3):346-50. PubMed ID: 12021624
[TBL] [Abstract][Full Text] [Related]
39. Pharmacodynamic monitoring of nuclear factor of activated T cell-regulated gene expression in liver allograft recipients on immunosuppressive therapy with calcineurin inhibitors in the course of time and correlation with acute rejection episodes--a prospective study.
Steinebrunner N; Sandig C; Sommerer C; Hinz U; Giese T; Stremmel W; Zahn A
Ann Transplant; 2014 Jan; 19():32-40. PubMed ID: 24457606
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients.
Frassetto LA; Browne M; Cheng A; Wolfe AR; Roland ME; Stock PG; Carlson L; Benet LZ
Am J Transplant; 2007 Dec; 7(12):2816-20. PubMed ID: 17949460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
